Search

You searched for "pharmaceuticals"

172 results found

Moorfields: Therapeutics CPD course for optometrists

19 November 2025 -20 November 2025
The Optometry Education Team is pleased to offer a comprehensive CPD course for hospital and community-based optometrists with an interest in the therapeutic management of ocular conditions.
Neuro-Ophthalmology journal cover image

Can coenzyme Q10 have a protective role in ethambutol-induced retinal ganglion cell toxicity

3 April 2023 | | EYE - Neuro-ophthalmology | Ethambutol, coenzyme Q10, ethambutol toxic optic neuropathy, retinal ganglion cells, tuberculosis
Tuberculosis (TB) is one of the most prevalent infectious diseases, especially in developing or low- income countries. Ethambutol is a widely used drug to treat TB. Ethambutol can cause visual disturbance including ethambutol toxic optic neuropathy (ETON). ETON is one...

A practical guide to anisocoria

1 February 2018 | | EYE - Neuro-ophthalmology, EYE - General
Anisocoria means the presence of difference in the size of the right and left pupils. It is a sign of an abnormality in the efferent pathway. The first question facing the ophthalmologist is to ascertain if anisocoria is present or...

Diabetes and diabetic retinopathy: Changes in understanding of the disease over the last 25 years and how the UK is helping low-income countries tackle the challenges

1 June 2018 | | EYE - Vitreo-Retinal, EYE - General
Diabetes – a historical perspective Diabetes mellitus (DM) is a chronic disease caused by inherited and / or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. Such a deficiency results in...

Insights on medical AI for ophthalmology: an update on current perspectives

3 June 2024 | | EYE - General
Artificial intelligence (AI) has immense promise for revolutionising medical practice. Generative AI is a form of AI in which algorithms are trained on datasets that can be used to generate new content, such as text, images or video based on...

See sweet to C-suite: Imran Rahman

4 February 2025 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma
See also - See sweet to C-suite: Peter Holland In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part Two: David speaks...

See sweet to C-suite: Carrie MacEwen

2 April 2025 | | EYE - General
The business world tells us, “Know your why.” But increasingly, we live in a society where people think, “Why bother?” In this interview, David wants to know what makes Carrie MacEwen tick, and why she bothered to get involved locally,...

Progress in retinal disease management: Highlights of the Retina Day, RCOphth 2025 Annual Congress

4 August 2025 | | EYE - Vitreo-Retinal
The Retina Day meeting at the Royal College of Ophthalmologists (RCOphth) 2025 Annual Congress in Liverpool was held on 22 May 2025. This report highlights 10 selected topics of interest to subspecialists and general ophthalmologists. Decarbonising anti-VEGF clinics (or making...

New study uncovers key mechanism behind a common genetic cause of age-related visual loss

19 September 2024 | endothelial cells, age, vision loss, research, academic, new, genetics, genome, Fuchs Endothelial Corneal Dystrophy, FECD
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...

Technology in ophthalmology – a promising future and what we need to know about the regulations

1 October 2017 | | EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Orbit, EYE - Vitreo-Retinal, EYE - General
Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...

The David J Apple International Laboratory for Ocular Pathology – a legacy of pioneering IOL research

1 October 2016 | | EYE - Cataract, EYE - Refractive
David Apple and Gerd Auffarth. The Apple Lab at the David J Apple Center for Vision Research in Heidelberg is a thriving international laboratory for research into intraocular devices. The lab continues the work of David J Apple, a world-renowned...

An eyeful of independence

1 August 2014 | | EYE - General
Scots will decide this September whether or not Scotland should be an independent sovereign state. “As all key areas of our business are already fully devolved, it’s very much business as usual for us,” noted a spokesperson for Healthcare Improvement...